Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: A meta-analysis

Diabetes Research and Clinical Practice

Volumn 106, Issue 1, 2014, Pages 88-94

  Feng, Rennan ^a   Li, Yanchuan ^a   Wang, Cheng ^a   Luo, Chao ^c   Liu, Liyan ^a   Chuo, Fuchuan ^a   Li, Qiang ^b   Sun, Changhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Diabetes; Meta analysis; Obesity; Vaspin

Indexed keywords

VASPIN; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN;

ARTICLE; BODY MASS; CONFIDENCE INTERVAL; ETHNICITY; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; COMPLICATION; META ANALYSIS; METABOLISM;

DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; SERPINS;

EID: 84908049523     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.07.026     Document Type: Article

References (30)

1. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
2. Harwood H.J. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 2012, 63:57-75.
3. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
4. Bluher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diab 2009, 117:241-250.
5. Bluher M. The inflammatory process of adipose tissue. Pediatr Endocrinol Rev 2008, 6:24-31.
6. Hida K., Wada J., Eguchi J., Zhang H., Baba M., et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 2005, 102:10610-10615.
7. Jung C.H., Lee W.J., Hwang J.Y., Seol S.M., Kim Y.M., et al. Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res Commun 2011, 413:264-269.
8. Youn B.S., Kloting N., Kratzsch J., Lee N., Park J.W., et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008, 57:372-377.
9. Derosa G., Fogari E., D'Angelo A., Bianchi L., Bonaventura A., et al. Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation 2013, 36:914-920.
10. Cho J.K., Han T.K., Kang H.S. Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur J Appl Physiol 2010, 108:347-353.
11. Jeong E., Youn B.S., Kim D.W., Kim E.H., Park J.W., et al. Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. J Clin Endocrinol Metab 2010, 95:1869-1875.
12. Teshigawara S., Wada J., Hida K., Nakatsuka A., Eguchi J., et al. Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J Clin Endocrinol Metab 2012, 97:E1202-E1207.
13. Zhang L., Li L., Yang M., Liu H., Yang G. Elevated circulating vaspin levels were decreased by rosiglitazone therapy in T2DM patients with poor glycemic control on metformin alone. Cytokine 2011, 56:399-402.
14. Gulcelik N.E., Karakaya J., Gedik A., Usman A., Gurlek A. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 2009, 160:65-70.
15. Ye Y., Hou X.H., Pan X.P., Lu J.X., Jia W.P. Serum vaspin level in relation to postprandial plasma glucose concentration in subjects with diabetes. Chin Med J (Engl) 2009, 122:2530-2533.
16. Seeger J., Ziegelmeier M., Bachmann A., Lossner U., Kratzsch J., et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 2008, 93:247-251.
17. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. J Am Med Assoc 2000, 283:2008-2012.
18. El-Mesallamy H.O., Kassem D.H., El-Demerdash E., Amin A.I. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism 2011, 60:63-70.
19. Choi S.H., Kwak S.H., Lee Y., Moon M.K., Lim S., et al. Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol (Oxf) 2011, 75:628-635.
20. Kim J.M., Kim T.N., Won J.C. Association between serum vaspin level and metabolic syndrome in healthy korean subjects. Metab Syndr Relat Disord 2013, 11:385-391.
21. Maedler K., Tönjes A., Fasshauer M., Kratzsch J., Stumvoll M., et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLOS ONE 2010, 5:e13911.
22. Li K., Li L., Yang M., Liu H., Liu D., et al. Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity. Eur J Endocrinol 2011, 164:905-910.
23. Feng R.-N. Vaspin in newly and previously diagnosed Chinese type 2 diabetic females: a case-control study. Asian Biomed 2011, 5:525-529.
24. Li Z., Ma C., Li L., Pan X., Chen L. Vaspin serum concentration in patients with type 2 diabetes and carotid plaque. J Int Med Res 2012, 40:1670-1676.
25. Bjorntorp P. Metabolic implications of body fat distribution. Diab Care 1991, 14:1132-1143.
26. Frayn K.N. Visceral fat and insulin resistance - causative or correlative?. Br J Nutr 2000, 83(Suppl. 1):S71-S77.
27. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000, 21:697-738.
28. Kempf K., Rose B., Illig T., Rathmann W., Strassburger K., et al. Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA/KORA studies. Exp Clin Endocrinol Diab 2010, 118:184-189.
29. Hashemi M., Rezaei H., Eskandari-Nasab E., Kaykhaei M.A., Zakeri Z., et al. Association between chemerin rs17173608 and vaspin rs2236242 gene polymorphisms and the metabolic syndrome, a preliminary report. Gene 2012, 510:113-117.
30. Lee M.K., Jekal Y., Im J.A., Kim E., Lee S.H. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification. Clin Chim Acta 2010, 411:381-385.